SBIR-STTR Award

Rational Design of Small Interfering Rna for Genome-Wide Target Knockdown
Award last edited on: 9/11/17

Sponsored Program
STTR
Awarding Agency
NIH : NHGRI
Total Award Amount
$697,079
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Xiaowei Wang

Company Information

Nawgen LLC

4320 Forest Park Avenue Suite 303
Saint Louis, MO 63108
   (314) 485-9642
   info@nawgen.com
   www.nawgen.com

Research Institution

Washington University

Phase I

Contract Number: 1R41HG008567-01A1
Start Date: 9/22/15    Completed: 8/31/17
Phase I year
2015
Phase I Amount
$347,147
RNA interference (RNAi) is a small RNA-guided gene silencing process within living cells. The RNAi technique is widely used in both biological research and clinical applications because it has the ability to knockdown essentially any gene of interest. However, one major unresolved issue in RNAi studies is non-specific gene silencing. It is well known that, in addition to the single intended gene target, many unintended targets are also simultaneously silenced. Thus, there is an urgent need to develop new methods for improving RNAi specificity. RNAi specificity and potency are determined by the small interfering RNA (siRNA) in the silencing complex. We propose the hypothesis that gene silencing specificity can be significantly improved with rational siRNA design. We have previously developed a machine learning algorithm for the design of widely-distributed commercial siRNAs. Based on this commercial success, we propose to further develop a new method for genome-wide design of next-generation siRNAs with significantly reduced off-target effects. The new design method will lay a solid foundation for further commercial development of siRNA products that can be used in a variety of RNAi-based applications.

Public Health Relevance Statement:


Public Health Relevance:
RNA interference (RNAi) is a small RNA-guided gene silencing process within living cells. RNAi has many diverse applications as it can suppress almost any human genes by recognizing the gene sequence. We propose to remove a major hurdle in RNAi studies by genome-wide design of siRNAs with significantly improved gene silencing specificity.

NIH Spending Category:
Biotechnology; Genetics; Human Genome

Project Terms:
Algorithm Design; Algorithms; Applications Grants; base; Bioinformatics; biological research; Cataloging; Catalogs; Cells; clinical application; Communities; Complex; Computer Simulation; Data; Databases; design; Development; Experimental Models; Foundations; gene function; Gene Silencing; Gene Targeting; Genes; Genetic Transcription; genome-wide; genome-wide analysis; Goals; High-Throughput RNA Sequencing; Human; improved; Individual; interest; Libraries; Life; Machine Learning; Methods; Modeling; Mus; next generation; Process; public health relevance; Research; Resources; RNA; RNA Interference; RNA Sequence Analysis; RNA Sequences; Services; Small Interfering RNA; Small RNA; Solid; Specificity; success; Techniques; Technology; Therapeutic; Time; tool; transcriptome sequencing; Validatio

Phase II

Contract Number: 5R41HG008567-02
Start Date: 9/22/15    Completed: 8/31/17
Phase II year
2016
Phase II Amount
$349,932
RNA interference (RNAi) is a small RNA-guided gene silencing process within living cells. The RNAi technique is widely used in both biological research and clinical applications because it has the ability to knockdown essentially any gene of interest. However, one major unresolved issue in RNAi studies is non-specific gene silencing. It is well known that, in addition to the single intended gene target, many unintended targets are also simultaneously silenced. Thus, there is an urgent need to develop new methods for improving RNAi specificity. RNAi specificity and potency are determined by the small interfering RNA (siRNA) in the silencing complex. We propose the hypothesis that gene silencing specificity can be significantly improved with rational siRNA design. We have previously developed a machine learning algorithm for the design of widely-distributed commercial siRNAs. Based on this commercial success, we propose to further develop a new method for genome-wide design of next-generation siRNAs with significantly reduced off-target effects. The new design method will lay a solid foundation for further commercial development of siRNA products that can be used in a variety of RNAi-based applications.

Public Health Relevance Statement:


Public Health Relevance:
RNA interference (RNAi) is a small RNA-guided gene silencing process within living cells. RNAi has many diverse applications as it can suppress almost any human genes by recognizing the gene sequence. We propose to remove a major hurdle in RNAi studies by genome-wide design of siRNAs with significantly improved gene silencing specificity.

NIH Spending Category:
Bioengineering; Biotechnology; Genetics; Human Genome

Project Terms:
Algorithm Design; Algorithms; Applications Grants; base; Bioinformatics; biological research; Cataloging; Catalogs; Cells; clinical application; Communities; Complex; Computer Simulation; Data; Databases; design; Development; Experimental Models; Foundations; gene function; Gene Silencing; Gene Targeting; Genes; Genetic Transcription; genome-wide; genome-wide analysis; Goals; High-Throughput RNA Sequencing; Human; improved; Individual; interest; knock-down; learning strategy; Libraries; Life; Machine Learning; Methods; Modeling; Mus; next generation; Process; public health relevance; Research; Resources; RNA; RNA Interference; RNA interference screen; RNA Sequence Analysis; Services; Small Interfering RNA; Small RNA; Solid; Specificity; success; Techniques; Technology; Therapeutic; Time; tool; transcriptome sequencing; Validation